RTOG 1010
Title:
A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma
Available at:
CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
For more information about this clinical trial, click
here